P38γ activity is required for maintenance of slow skeletal muscle size

Muscle and Nerve

Volumn 45, Issue 2, 2012, Pages 266-273

  Foster, William H ^a   Tidball, James G ^a   Wang, Yibin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Development; Mice; P38 ; Phosphorylation; Skeletal muscle

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 GAMMA; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; ENZYME ACTIVITY; FAST MUSCLE; GENE EXPRESSION; HISTOLOGY; MOUSE; MUSCLE CELL; MUSCLE DEVELOPMENT; MUSCLE GROWTH; MUSCLE MASS; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; SLOW MUSCLE; SOLEUS MUSCLE;

ANIMALS; CALCINEURIN; GENE EXPRESSION REGULATION; GLUCOSE TRANSPORTER TYPE 4; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE FIBERS, SLOW-TWITCH; MYOSIN HEAVY CHAINS; ORGAN SIZE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PPAR GAMMA; RNA, MESSENGER; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 84862954226     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.22289     Document Type: Article

References (28)

1. Keren A, Tamir Y, Bengal E. The p38γMAPK signaling pathway: a major regulator of skeletal muscle development. Mol Cell Endocrinol 2006;252:224-230.
2. Ono K, Han J. The p38γsignal transduction pathway: activation and function. Cell Signal 2000;12:1-13.
3. Lu G, Kang YJ, Han J, Herschman HR, Stefani E, Wang Y. TAB-1 modulates intracellular localization of p38γMAP kinase and downstream signaling. J Biol Chem 2006;281:6087-6095.
4. Salvador JM, Mittelstadt PR, Guszczynski T, Copeland TD, Yamaguchi H, Appella E, et al. Alternative p38γactivation pathway mediated by T cell receptor-proximal tyrosine kinases. Nat Immunol 2005;6: 390-395.
5. de Angelis L, Zhao J, Andreucci JJ, Olson EN, Cossu G, McDermott JC. Regulation of vertebrate myotome development by the p38γMAP kinase-MEF2 signaling pathway. Dev Biol 2005;283:171-179.
6. Keren A, Bengal E, Frank D. p38γMAP kinase regulates the expression of XMyf5 and affects distinct myogenic programs during Xenopus development. Dev Biol 2005;288:73-86.
7. Tamura K, Sudo T, Senftleben U, Dadak AM, Johnson R, Karin M. Requirement for p38γlpha in erythropoietin expression: a role for stress kinases in erythropoiesis. Cell 2000;102:221-231.
8. Adams RH, Porras A, Alonso G, Jones M, Vintersten K, Panelli S, et al. Essential role of p38γlpha MAP kinase in placental but not embryonic cardiovascular development. Mol Cell 2000;6:109-116.
9. Perdiguero E, Ruiz-Bonilla V, Gresh L, Hui L, Ballestar E, Sousa- Victor P, et al. Genetic analysis of p38γMAP kinases in myogenesis: fundamental role of p38γlpha in abrogating myoblast proliferation. EMBO J 2007;26:1245-1256.
10. Bellon S, Fitzgibbon MJ, Fox T, Hsiao HM, Wilson KP. The structure of phosphorylated p38γamma is monomeric and reveals a conserved activation-loop conformation. Structure 1999;7:1057-1065.
11. Tortorella LL, Lin CB, Pilch PF. ERK6 is expressed in a developmentally regulated manner in rodent skeletal muscle. Biochem Biophys Res Commun 2003;306:163-168.
12. Lechner C, Zahalka MA, Giot JF, Moller NP, Ullrich A. ERK6, a mitogen-activated protein kinase involved in C2C12 myoblast differentiation. Proc Natl Acad Sci USA 1996;93:4355-4359.
13. Mertens S, Craxton M, Goedert M. SAP kinase-3, a new member of the family of mammalian stress-activated protein kinases. FEBS Lett 1996;383:273-276.
14. Li Z, Jiang Y, Ulevitch RJ, Han J. The primary structure of p38γ: a new member of p38γgroup of MAP kinases. Biochem Biophys Res Commun 1996;228:334-340.
15. Pogozelski AR, Geng T, Li P, Yin X, Lira VA, Zhang M, et al. p38γamma mitogen-activated protein kinase is a key regulator in skeletal muscle metabolic adaptation in mice. PLoS One 2009;4: e7934.
16. Wu H, Naya FJ, McKinsey TA, Mercer B, Shelton JM, Chin ER, et al. MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type. EMBO J 2000;19:1963-1973.
17. Naya FJ, Mercer B, Shelton J, Richardson JA, Williams RS, Olson EN. Stimulation of slow skeletal muscle fiber gene expression by calcineurin in vivo. J Biol Chem 2000;275:4545-4548.
18. Dunn SE, Burns JL, Michel RN. Calcineurin is required for skeletal muscle hypertrophy. J Biol Chem 1999;274:21908-21912.
19. Chin ER, Olson EN, Richardson JA, Yang Q, Humphries C, Shelton JM, et al. A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev 1998;12:2499-2509.
20. Potthoff MJ, Wu H, Arnold MA, Shelton JM, Backs J, McAnally J, et al. Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers. J Clin Invest 2007;117: 2459-2467.
21. Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, Boss O, et al. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 2002;418:797-801.
22. Handschin C, Chin S, Li P, Liu F, Maratos-Flier E, Lebrasseur NK, et al. Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1alpha muscle-specific knock-out animals. J Biol Chem 2007;282:30014-30021.
23. Wang X, McGowan CH, Zhao M, He L, Downey JS, Fearns C, et al. Involvement of the MKK6-p38γamma cascade in gamma-radiationinduced cell cycle arrest. Mol Cell Biol 2000;20:4543-4552.
24. Court NW, Kuo I, Quigley O, Bogoyevitch MA. Phosphorylation of the mitochondrial protein Sab by stress-activated protein kinase 3. Biochem Biophys Res Commun 2004;319:130-137.
25. Court NW, Ingley E, Klinken SP, Bogoyevitch MA. Outer membrane protein 25-a mitochondrial anchor and inhibitor of stress-activated protein kinase-3. Biochim Biophys Acta 2005;1744:68-75.
26. Carlson CJ, Fan Z, Gordon SE, Booth FW. Time course of the MAPK and PI3-kinase response within 24 h of skeletal muscle overload. J Appl Physiol 2001;91:2079-2087.
27. Tsika RW, Herrick RE, Baldwin KM. Subunit composition of rodent isomyosins and their distribution in hindlimb skeletal muscles. J Appl Physiol 1987;63:2101-2110.
28. Shi H, Zeng C, Ricome A, Hannon KM, Grant AL, Gerrard DE. Extracellular signal-regulated kinase pathway is differentially involved in beta-agonist-induced hypertrophy in slow and fast muscles. Am J Physiol Cell Physiol 2007;292:C1681-C1689.